Prevention of nephrolithiasis by Lactobacillus in stone-forming rats: A preliminary study

Urological Research

Volumn 34, Issue 4, 2006, Pages 265-270

  Kwak, Cheol ^a   Jeong, Byong Chang ^a   Ku, Ja Hyeon ^a   Kim, Hyeon Hoe ^a   Lee, Jeong Jun ^b   Huh, Chul Sung ^b   Baek, Young Jin ^b   Lee, Sang Eun ^c  

^a Seoul National University Hospital   (South Korea)

^b Korea Yakult Co   (South Korea)

^c Seoul National University Bundang Hospital   (South Korea)

Author keywords

Lactobacillus; Nephrolithiasis; Oxalate; Rat

Indexed keywords

CITRIC ACID; OXALIC ACID DERIVATIVE;

ANIMAL; ARTICLE; BODY WEIGHT; CRYSTALLIZATION; KIDNEY; LACTOBACILLUS; MALE; METABOLISM; NEPHROLITHIASIS; PILOT STUDY; RAT; SPRAGUE DAWLEY RAT; URINE;

ANIMALS; BODY WEIGHT; CITRIC ACID; CRYSTALLIZATION; KIDNEY; KIDNEY CALCULI; LACTOBACILLUS; MALE; OXALATES; PILOT PROJECTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33750618975     PISSN: 03005623     EISSN: 14340879     Source Type: Journal    
DOI: 10.1007/s00240-006-0054-4     Document Type: Article

References (20)

1. Kim H, Jo MK, Kwak C, Park SK, Yoo KY, Kang D, Lee C (2002) Prevalence and epidemiologic characteristics of urolithiasis in Seoul, Korea. Urology 59:517
2. Uribarri J, Oh MS, Carroll HJ (1989) The first kidney stone. Ann Intern Med 111:1006
3. Byeon SS, Kim HH, Kim SH (1996) Analysis of the urinary stone components using chemical analysis method. Korean J Urol 37:179
4. von Unruh GE, Voss S, Sauerbruch T, Hesse A (2003) Reference range for gastrointestinal oxalate absorption measured with a standardized [13C2]oxalate absorption test. J Urol 169:687
5. Chadwick VS, Modha K, Dowling RH (1973) Mechanism for hyperoxaluria in patients with ileal dysfunction. N Engl J Med 289:172
6. Smith LH, Fromm H, Hofmann AF (1972) Acquired hyperoxaluria, nephrolithiasis, and intestinal disease. Description of a syndrome. N Engl J Med 286:1371
7. Allison MJ, Dawson KA, Mayberry WR, Foss JG (1985) Oxalobacter formigenes gen. nov., sp. nov.: oxalate-degrading anaerobes that inhabit the gastrointestinal tract. Arch Microbiol 141:1
8. Kwak C, Jeong BC, Lee JH, Kim HK, Kim EC, Kim HH (2001) Molecular identification of Oxalobacter formigenes with the polymerase chain reaction in fresh or frozen fecal samples. BJU Int 88:627
9. Hokama S, Honma Y, Toma C, Ogawa Y (2000) Oxalate-degrading Enterococcus faecalis. Microbiol Immunol 44:235
10. Hida M, Aiba Y, Sawamura S, Suzuki N, Satoh T, Koga Y (1996) Inhibition of the accumulation of uremic toxins on the blood and their precursors in the feces after oral administration of Lebenin, a lactic acid bacteria preparation, to uremic patients undergoing hemodialysis. Nephron 74:349
11. Dunn SR, Simenhoff ML, Ahmed KE (1998) Effect of oral administration of freeze-dried Lactobacillus acidophilus on small bowel bacterial overgrowth in patients with end stage kidney disease: reducing uremic toxins and improving nutrition. Int Dairy J 8:545
12. Campieri C, Campieri M, Bertuzzi V, Swennen E, Matteuzzi D, Matteuzzi D, Stefoni S, Pirovano F, Centi C, Ulisse S, Famularo G, De Simone C (2001) Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration. Kidney Int 60:1097
13. Jeong BC, Park MY, Kwak C, Kim BS, Kim JI, Kim HH (2005) An animal model of calcium oxalate urolithiasis based on a cyclooxygenase 2 selective inhibitor. Urol Res 33:453
14. Barber HM, Gallimore EJ (1940) The metabolism of oxalic acid in the animal body. Biochem J 34:144
15. Allison MJ, Cook HM, Milne DB, Gallagher S, Clayman RV (1986) Oxalate degradation by gastrointestinal bacteria from humans. J Nutr 116:455
16. Kumar S, Sigmon D, Miller T, Carpenter B, Khan S, Malhotra R, Scheid C, Menon M (1991) A new model of nephrolithiasis involving tubular dysfunction/injury. J Urol 146:1384
17. Allison M, Daniel SL, Cormick NA (1995) Oxalate degrading bacteria. In: Kahn SR (eds) Calcium oxalate in biological systems. CRC, Boca Raton, pp 131-169
18. Sidhu H, Ogden SD, Lung HY, Luttge BG, Baetz AL, Peck AB (1997) DNA sequencing and expression of the formyl coenzyme A transferase gene, frc, from Oxalobacter formigenes. J Bacteriol 179:3378
19. Sidhu H, Hoppe B, Hesse A, Tenbrock K, Bromme S, Rietschel E, Peck AB (1998) Absence of Oxalobacter formigenes in cystic fibrosis patients: a risk factor for hyperoxaluria. Lancet 352:1026
20. Kwak C, Oh JE, Kim HK, Choi MS, Kim EC, Kim HH (2003) Isolation and purification of the oxalate-degrading bacterium Oxalobacter formigenes in human feces. Korean J Urol 44:785